0001842952-22-000022.txt : 20220225 0001842952-22-000022.hdr.sgml : 20220225 20220225164319 ACCESSION NUMBER: 0001842952-22-000022 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220225 FILED AS OF DATE: 20220225 DATE AS OF CHANGE: 20220225 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Levit Alex C. CENTRAL INDEX KEY: 0001862840 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40654 FILM NUMBER: 22681071 MAIL ADDRESS: STREET 1: 3675 MARKET STREET STREET 2: SUITE 200 CITY: PHILADELPHIA STATE: PA ZIP: 19104 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Context Therapeutics Inc. CENTRAL INDEX KEY: 0001842952 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 863738787 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3675 MARKET STREET STREET 2: SUITE 200 CITY: PHILADELPHIA STATE: PA ZIP: 19104 BUSINESS PHONE: 267-225-7416 MAIL ADDRESS: STREET 1: 3675 MARKET STREET STREET 2: SUITE 200 CITY: PHILADELPHIA STATE: PA ZIP: 19104 FORMER COMPANY: FORMER CONFORMED NAME: Context Therapeutics LLC DATE OF NAME CHANGE: 20210128 4 1 wf-form4_164582536740296.xml FORM 4 X0306 4 2022-02-25 0 0001842952 Context Therapeutics Inc. CNTX 0001862840 Levit Alex C. 2001 MARKET STREET SUITE 3915, UNIT #15 PHILADELPHIA PA 19103 0 1 0 0 Chief Legal Officer, Corp. Sec Stock Option (right to buy) 1.79 2022-02-25 4 A 0 107870 0 A 2032-02-24 Common Stock 107870.0 107870 D The option vests and becomes exercisable over a four-year period. Twenty-five percent (25%) of the option vests and becomes exercisable on February 25, 2023, and the balance vests in equal monthly installments (rounded down to the nearest whole share) over the remaining three years of the four-year period, subject to continued service with the Issuer. /s/ Alex Levit, Attorney-in-Fact 2022-02-25